{"data":{"type":"company_profile","id":135919,"entity_id":"wefunder:company:135919","attributes":{"canonical_url":"https://wefunder.com/achieve.clinics.inc","generated_at":"2026-06-25T21:27:51Z","updated_at":"2026-06-25T05:02:21Z","entity_ids":{"company":"wefunder:company:135919","slug":"wefunder:company_slug:achieve.clinics.inc"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-25T21:27:51Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-25T05:02:21Z","as_of":"2026-06-25T21:27:51Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-25T05:02:21Z","as_of":"2026-06-25T21:27:51Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-21T17:54:49Z","as_of":"2026-06-25T21:27:51Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-21T17:54:49Z","as_of":"2026-06-25T21:27:51Z","confidence":"medium"}}},"company":{"id":135919,"entity_id":"wefunder:company:135919","slug":"achieve.clinics.inc","name":"Achieve Clinics, Inc.","tagline":"Free-to-patient immune cell banking to supercharge cancer cell therapy access and innovation ","story":"Forward looking projections cannot be guaranteed.Forward looking projections cannot be guaranteed.","location":"Los Angeles, CA","website":"https://achieveclinics.com","total_amount_raised":53518,"total_investors":7,"is_funded":true,"is_active":true,"related_urls":["https://wefunder.com/achieve.clinics.inc","https://achieveclinics.com"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/135919/xxl_blob.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/135919/large_blob.png","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/135919/standard_blob.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/135919/standard_blob.jpg"},"links":{"company_url":"https://achieveclinics.com","linkedin_url":"https://linkedin.com/company/achieveclinics"},"highlights":[],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"We proactively bank cancer patient immune cells for cell therapy (incl. pre-chemo) at no cost"},{"index":2,"claim_id":"claim-fact-2","value":"With us, industry can now pre-enroll patients for studies and manufacture with \"off-the-shelf\" cells"},{"index":3,"claim_id":"claim-fact-3","value":"Our unique platform generates invaluable large-format, patient records-linked research biomaterial"},{"index":4,"claim_id":"claim-fact-4","value":"Free-to-patient model fueled by PRO-Aph specimen sales: LOIs reflect ~$0.3m+/pt in potential demand"},{"index":5,"claim_id":"claim-fact-5","value":"Launch network incl. leaders from Genentech, Penn, Be The Match, xCures, +dozens in active pipeline"},{"index":6,"claim_id":"claim-fact-6","value":"Initial oncologist support and collection (apheresis) sites expected in Seattle and Houston"},{"index":7,"claim_id":"claim-fact-7","value":"Proudly endorsed by the Emily Whitehead Foundation (https://emilywhiteheadfoundation.org/)"}],"team":[{"id":3556431,"entity_id":"wefunder:company_role:3556431","user_entity_id":"wefunder:user:2894894","role":"founder","name":"Paul Chun","title":"Chief Financial Officer, Co-Founder","bio":"~20 year biotech veteran with background in investment research, capital markets, corporate development, and finance, including public biotech Board of Directors. Track record of several IPOs, financings, licensing, etc., incl. in cancer immunotherapy.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/3556431/square_blob.jpg?1692135349","profile_url":"https://wefunder.com/paulchun","linkedin_url":"https://linkedin.com/in/paulchun","related_urls":["https://wefunder.com/paulchun"]},{"id":3560863,"entity_id":"wefunder:company_role:3560863","role":"founder","name":"Brad Heller","title":"Chief Executive Officer, Founder","bio":"UCSF-trained neuro and cell biology specialist with biopharma startup experience across CAR-TCR and drug discovery. Finally got fed up with seeing curative cell therapies get stuck behind apheresis appointment backlogs and chemo-cooked cells.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/3560863/square_blob.jpg?1686216330","linkedin_url":"https://linkedin.com/in/bradhellerphd/","related_urls":[]}],"featured_investors":[{"id":1170,"entity_id":"wefunder:company_investor_profile:1170","investor_profile_id":3633493,"investor_profile_entity_id":"wefunder:investor_profile:3633493","subject_entity_id":"wefunder:notable_investor:6921","name":"Brazen Bio","bio":"Helping biotech founders advance human health.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MzIwMDQsInB1ciI6ImJsb2JfaWQifX0=--7503a28baaa251dffad5f4b5ea0685ca72854388/Screenshot%202023-10-13%20at%201.11.47%20PM.png","profile_url":"https://wefunder.com/brazen.bio.1","is_lead_investor":false,"related_urls":["https://wefunder.com/brazen.bio.1"]},{"id":4855,"entity_id":"wefunder:company_investor_profile:4855","investor_profile_id":2685941,"investor_profile_entity_id":"wefunder:investor_profile:2685941","subject_entity_id":"wefunder:user:3223213","name":"Brazen Capital","bio":"Launching the next generation of scientist-CEOs including at least 50% women CEOs.","avatar_url":"http://uploads.wefunder.com/uploads/user/avatar/3223213/medium_cropped_BrCa-Logo-crispy-b-roygbiv-desktop.jpg","profile_url":"https://wefunder.com/brazencapital","endorsement_quote":"Brazen Capital is launching the next generation of scientist-CEOs at the earliest stages of their startup journey in biomedicine. Our unique value-add is we (co-GPs Shawn Carbonell, MD, PhD and Monica Berrondo, PhD [YC W18]) have been scientist-CEOs ourselves for over a decade each. Unlike most VCs, we've lived that life. Brad Heller, PhD and I met randomly in November 2021 on LunchClub, of all places. This was a time before we had even launched the fund, but after listening to him passionately explain what he was working on during that short video conference call, I placed him in my mental pipeline of founders to potentially invest in. Over the subsequent months, what Monica and I confirmed is this is an impressive founder leveraging his deep technical expertise to solve a major problem he personally identified while working in the cell therapy industry. With the addition of highly experienced biotech executive and cofounder, Paul Chun, we are extremely bullish about their potential for dramatically improving patient outcomes in the multi-billion dollar cell therapy space. We are proud to be the first investors in Achieve Clinics and welcome you to join us. W. Shawn Carbonell, MD, PhD Founding Partner, Brazen Capital","investment_total":12500,"investment_info":"Invested $2,500 this round \u0026 $10,000 previously","is_lead_investor":true,"related_urls":["https://wefunder.com/brazencapital"]}],"investor_memos":[],"tab_counts":{"posts":0,"ask_questions":1,"featured_investors":2,"faq_entries":1},"active_fundraises":[{"id":86427,"entity_id":"wefunder:fundraise:86427","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"convertible_note","security_type":"debt","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":50000.0,"minimum_target":"50000.0","maximum_target":"120000.0","funding_started_at":"2023-09-12T19:24:16Z","funding_closed_at":"2023-12-02T05:01:50Z","auto_close_at":"2023-12-02T04:59:59Z"},{"id":86428,"entity_id":"wefunder:fundraise:86428","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":50000.0,"minimum_target":"50000.0","maximum_target":"120000.0","funding_started_at":"2023-05-01T17:16:48Z"}],"latest_fundraise":{"id":86427,"entity_id":"wefunder:fundraise:86427","state":"successful","offering_type":"4(a)(6)","structure":"convertible_note","testing_the_waters":false,"can_invest_now":false,"funding_started_at":"2023-09-12T19:24:16Z","funding_closed_at":"2023-12-02T05:01:50Z","terms":{"eb":null,"nb":"$5M","txt":"valuation cap"}},"recent_posts":[],"q_and_a":[{"id":263408,"entity_id":"wefunder:comment:263408","question":"Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?","author_name":"Teddy Lyons","votes":0,"created_at":"2023-09-26T17:42:20Z","canonical_url":"https://wefunder.com/achieve.clinics.inc#question-263408","answers":[{"id":263412,"entity_id":"wefunder:comment:263412","answer":"Hi Teddy, Thanks for your questions. a) Excluding one-off items like conferences, our monthly burn is minimal at approximately $100. Once cell collection and processing activities begin, we expect those to incur expenses in the single-digit thousands or more per patient. b) Our cash on hand remains materially similar to the last reported balance of $883 c) We remain engaged with angels and VCs, but the only raise terms discussed currently are what you see here. As proud and excited as we are of our prospective partners and investors, we are not at liberty to identify any we have not already disclosed so far. Thanks again!","author_name":"Paul Chun","votes":0,"created_at":"2023-09-26T18:18:21Z"}]}],"faq":[{"question":"Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?","answer":"Hi Teddy, Thanks for your questions. a) Excluding one-off items like conferences, our monthly burn is minimal at approximately $100. Once cell collection and processing activities begin, we expect those to incur expenses in the single-digit thousands or more per patient. b) Our cash on hand remains materially similar to the last reported balance of $883 c) We remain engaged with angels and VCs, but the only raise terms discussed currently are what you see here. As proud and excited as we are ..."}]}}}